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For the research of COVID-19, the excess mortality has been adequate indicator for comparison of 
various situation from international point of view. The data of excess mortality in many countries 
were reported in Jan and April 2021. In current results for annual statistic, excess mortalities are US 
458,000, Italy 89,100, England 85,400, Spain 84,100, Poland 60,100, and New Zealand 2500. 
Previous data showed Taiwan -4800, Australia -4700, and Japan -15000. For COVID-19 pandemic, 
previous data of excess deaths from public report shows the possibility of underestimation. Several 
factors are presumably involved in COVID-19 impact including public health measures and 
influenza prevalence. 
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Commentary 
Concerning COVID-19, several projects were found for 
predicting death rate, such as calculation of age-related relative 
risk (RR) [1] and fatality rates [2]. The excess mortality has 
been adequate indicator for the research of COVID-19. The 
international data from 77 countries were previously 
summarized and reported, in which some representative data as 
US 420,000, Brazil 170,000, England 80,000, Italy 64,000, 
Germany 30,000, New Zealand -2,100, Taiwan -4,800 and 
Japan -15,000 [3]. The author reported detail situation of Japan 
with minus excess mortality from several points of view as well 
as future perspectives for human resources and life [4]. The 
estimation of excess mortality is based on the additive hazard 
model, which separates observed mortality hazard into expected 
mortality and excess period. For example, the result from 
analysis in UK showed that absolute excess risk was 703 per 
100,000 person-years (95% Cl 687-719) for about one third of a 
year. In 2018, excess risk was 902 for one year. Thus, the risk of 
1/3 year in 2020 equals to that of 3/4 year [5]. Most recent data 
of excess mortality were summarized for 29 high income 
countries [6]. Highest countries are US, Italy, UK, Spain and 
Poland, while New Zealand showed lower result. Overall men 
showed much higher than women. Both results of Jan and April 
2020 are compared (Table 1) [3,4,6]. In this article, several 
current reports are introduced.  
For COVID-19 pandemic, previous data of excess deaths from 
public report seemed to be underestimated. Then detail analysis 
was conducted by using the Joinpoint regression program [7]. 
Deaths in US was 1,336,561 during Mar-Aug 1, 2020, which 
was 20% more than expected. Out of 225,530 excess deaths, 
150,541 cases (67%) seemed to be attributed to COVID-19. In 
recent report, excess deaths were 2,801,439 during Mar-Dec 2000, 
which showed 22.9% increase than expected with 522,368 excess 
deaths [8]. Among them, three subgroups were analyzed, where 
non-Hispanic Black, non-Hispanic White, Hispanic population 
showed 208.4, 157.0, 139.8 deaths per 100,000, respectively. 
Further, the excess death ratio was 16.9%, 61.1%, 16.7%, 
respectively. COVID-19 has brought remarkable increase in all-
cause deaths in the US, which are mostly elder adults. In contrast, 
adults from 25-44 years were investigated [9]. The methods applied 
the data from Health and Human Services (HHS) in US. The results 
showed that all-cause deaths were 76,088 for Mar-July 2020 that 
was 11,899 more than expected 64,189 deaths (incident rate ratio 
1.19). Covid-19 deaths were 4,535, which was 38% of measured 
excess mortality. For HHS region including New York and new 
Jersey showed incident rate was 2.30. Age-specific mortality rate 
was compared between US and European countries. As a result, 
adverse mortality situations in the US showed 400,700 excess in 
2017 [10].  
Several studies are from European countries. Excess mortality for 
care home resident in UK was evaluated from Jan 2017 to Aug 
2020 [11]. The results showed that all care home was 6.5%, nursing 
home was 8.4% and residential home was 4.6% out of 29,542 
excess deaths. Among them, 64.7% of excess deaths were 
suspected or confirmed by COVID-19. Odds ratio for experiencing 
COVID-19 was 1.8 for nursing services, 5.5 for older people and/or 
with dementia. From Italy, relationship between care home 
facilities and excess deaths was conducted [12]. As a result, 
significant higher excess death was found for the presence of care 
homes in the municipality. Especially, this situation seems to be 
driven from elderly people of 70 years and older. The influence of 
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COVID-19 was studied for 31 nursing homes (NH) in Italy [13]. 
Totally 3,946 NH residents showed females 73.9% and 87 
years in median were included. Among them 1,136 was 
positive for COVID-19. As a result, the risk of death was 
increased as HR 1.85 by COVID-19. 
Table 1: Excess mortality metrics for the countries in the dataset. 
Country 
   Estimated number of excess deaths in 2020 
Islam ref.6 Karlinsky ref.3 
April 29,2021 Jan 27,2021 
United States 458000 420000 
Italy 89100 64000 
England & Wales 85400 80000 
Spain 84100 78000 
Poland 60100 67000 
France 43500 52000 
Germany 25900 30000 
Belgium 17900 18000 
Hungary 16600 11000 
Netherlands 15300 18000 
Czecho Republic 14400   
Sweden 9300 9400 
Portugal 8500 12000 
Greece 7700 4700 
Austria 6800 8600 
Scotland 6800   
Switzerland 6800 6400 
Lithuania 6800 6400 
Slovakia 4400 2500 
South Korea 4000 -2500 
Slovenia 3200 2800 
Nothern Ireland 2200   
Finland 1000 890 
Latvia 820 1700 
Estonia 670 620 
Norway -70 -20 
Denmark -160 650 
New Zealand -2500 -2100 
Mexico   270000 
Russia   270000 
Brazil   170000 
South Africa   96000 
Peru   93000 
Australia   -4700 
Taiwan   -4800 
Japan   -15000 
Israel is known to conduct early vaccination. Excess all-cause 
mortality rates were studied for Mar-Nov 2020 compared with 
2017-2019 [14]. Total mortality rate was significantly 6% 
higher, where 11%, 13%, 19% higher in Aug, Sept, and Oct, 
2020. Excess mortality was significantly 7% higher in 65-74/75-
84 years, and 8% higher in 85< years, and greater for males than 
females in all ages.  
Ecological analysis was performed for 22 countries compared with 
5-year historical all-cause mortality. There were excess deaths of 
716,616 compared to last 5 years, where 64.3% of them were 
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attributed to COVID-19. Consequently, deaths data would be 
underestimated by at least 35% by COVID-19 [15]. Excess 
mortality data show minus number in New Zealand, Taiwan and 
Japan. New Zealand conducted strict intervention of public 
health during middle March for 12th week of 2020, such as early 
border closure, compulsory self-isolation after travelling, 
nationwide lockdown, limited contacts and isolation of infected 
cases [16]. In combination with the geographical isolation, these 
effective interventions brought COIVD-19 elimination in early 
June, 2020 for 24th week [17]. Furthermore, persistent reduced 
mortality would be also from the absence of influenza epidemic 
in 2020. Consequently, both of public health measures and 
influenza prevalence were presumably involved in COVID-19 
elimination [18]. In Taiwan, COVID-19 affected confirmed 911 
cases, and 8 death until Jan 31, 2021 [19]. For statistic method, 
spline-smoothed Poisson regression models were used for death 
rate and seasonal effect from Jan 2015- Dec 2019. Then, 
expected deaths were calculated for Jan 2020 to Jan 2021, and 
excess deaths were estimated for -2,433 (95% CI: −10,715 to 
5,850) [20]. This method also enables the analysis of various 
cause of reduction in mortality from pneumonia and influenza 
[21].  
For Japan, healthcare access during COVID-19 impact was 
investigated for actual medical practice [22]. As a result, limited 
accessibility was found and future proposal for urgent 
supportive management against prolonged pandemics will be 
proposed. In summary, currently meaningful reports were 
described and discussed. The information will become hopefully 
useful for further research development. Conflict of interest: 
The author declares no conflict of interest.  
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